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Abstract
Background: Patients with breast cancer usually present varying levels of depressive symptoms. Emotional suppression,
as a coping style, refers to an individual’s ability to consciously control expression of negative emotions. Thus, emotional
suppression is an important psychological factor related to depressive symptoms in patients with breast cancer. It has
long been considered that compared to European and American women, Chinese women are more likely to ascribe to
norms of negative emotion control for smooth social interaction. However, there is paucity of research focusing
on emotional suppression among Chinese women with breast cancer. Thus the aims of the current study were
(1) to investigate the incidence of depressive symptoms in women newly diagnosed with early breast cancer in
Mainland China, and (2) to examine the relationships between emotional suppression and depressive symptoms
in these patients.
Methods: The Center for Epidemiological Studies Depression Scale (CES-D), the Beck Anxiety Inventory (BAI) and
the Chinese version of the Courtauld Emotional Control Scale (CECS) were used to assess the level of depressive
symptoms, anxiety symptoms and emotional suppression respectively in 247 women with early breast cancer and
362 healthy women. Analyses of variance were conducted to investigate group differences on depressive symptoms
and emotional suppression. Bivariate correlations and Hierarchical regression analyses were performed to examine the
effect of emotional suppression on depressive symptoms in participants after controlling the impact of group
membership and anxiety level.
Results: (1) The incidence rates of clinical and severe depressive symptoms in patients were 36.4 and 36.0 % respectively.
(2) Patients scored significantly higher than healthy women on CECS. (3) The scores on CECS were significantly associated
with the total CES-D scores in all participants; Anger suppression significantly predicted the total CES-D scores.
Conclusions: The majority of women newly diagnosed with early breast cancer reported clinical or severe depressive
symptoms. As well, these patients presented a controlled emotion coping style. Emotional suppression was associated
with the level of depressive symptoms in women newly diagnosed with breast cancer. Anger suppression might play a
unique role in the depressive symptoms among women newly diagnosed with breast cancer.
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Background
Breast cancer has been the most common malignancy
amongst women around the world [1]. In 2008, about
1.38 million women were diagnosed with breast cancer
and approximately 0.46 million women died of the dis-
ease worldwide [2]. China used to be a low-incidence
area of breast cancer, however, urban cancer registries
have documented 20 to 30 % increases in the incident
rates of breast cancer in the last decade [3]. Based on
data of the sixth national population census and the re-
cent national incidence of female breast cancer, it is esti-
mated that more than 270,000 Chinese women face the
risk of being diagnosed with breast cancer.
Being diagnosed with breast cancer is a catastrophic
life event, which usually induces psychological distress.
Extensive studies have shown that patients with breast
cancer usually present varying levels of depressive symp-
toms [4, 5]. For example, 5 to 15 % of post-surgery pa-
tients report depressive symptoms using structured
interviews. These percentages rise to 15 to 30 % when
using screening questionnaires [6]. Even years after diag-
nosis and treatment, some patients with breast cancer
still suffer from significant clinical depression [7, 8]. In
addition to decreasing physiological and psychological
function [9–12], depressive symptoms may have other
serious consequences, such as increasing mortality in pa-
tients with breast cancer [13].
Various factors are related to depressive symptoms in
patients with breast cancer, including demographics,
disease-related factors, and individual psychosocial char-
acteristics such as coping styles and personality traits
[14–17]. Emotional suppression, one of these coping
styles, is defined as an individual’s ability to consciously
control the expression of negative emotions, such as
anxiety, sadness, and anger. It is a core component of
the cancer personality trait, commonly referred to as
type C behavioral pattern elaborated by Temoshok [18].
Empirical evidence has been accumulated to support the
link between emotional suppression and psychosocial
maladjustment such as depressive symptoms in patients
with breast cancer [19]. For example, Schlatter et al. [20]
found that anger suppression was associated with higher
level of depression in breast cancer patients during
chemotherapy. Classen et al. [21] found that emotional
suppression as a whole was related to worse mood in
women with advanced breast cancer. Conversely, at-
tempts to express negative emotions could lead to better
adjustment to cancer [18, 22]. Emotional expression in a
supportive group environment enhanced the manage-
ment of disease-related emotion and reduced distress.
These findings suggest that a controlled emotion coping
style may hinder psychological adjustment to cancer. In
other words, sufficient emotional expression is import-
ant for breast cancer patients.
However, research to date has focused on western
women. Studies show that compared to European and
American women, Chinese women are more likely to
ascribe to norms of emotional control for ensuring
smooth social interactions [23]. Thus, emotional control
appears to have important implication for the psycho-
logical adjustment of Chinese patients with breast can-
cer. Despite its importance in the Chinese context, there
was only one study conducted by Ho and colleagues [24]
concerning Hong Kong Chinese women. Ho et al. re-
ported that women with cancer showed a tendency to
suppress emotion, and emotional suppression positively
predicted stress level even after the effect of depressed
mood was under control. But almost ten years has
passed since then, no evidence has indicated the rela-
tionships between emotional suppression and depressive
symptoms in women newly diagnosed with breast cancer
in Mainland China. Figuring out the role of emotional
suppression may help us to better understand the de-
pressive symptoms in patients, and to adopt useful inter-
vention strategies to improve their psychological
adjustment. Thus the aims of the current study were: (1)
to investigate the incidence of depressive symptoms in
the women newly diagnosed with early breast cancer in
mainland China, and (2) to examine the relationships
between emotional suppression and depressive symp-




Between September 2011 and June 2012, patients were
recruited from Xiangya Hospital and Second Xiangya
Hospital, Central South University. Eligible patients met
the following criteria: (1) women newly diagnosed with
breast cancer stage I or stage II by biopsy, (2) informed
of the diagnosis by their relatives or doctors, and (3)
ability to speak Chinese. Patients with the following con-
ditions were excluded: (1) breast cancer recurrence, (2)
known untreated or unstable major medical conditions
other than breast cancer, (3) known major psychiatric or
neurological disorders that would interfere with comple-
tion of the measures, and (4) history of substance abuse.
Two hundred and fifty-five women met the first three
inclusion criteria and were invited to the study. Eight of
them were excluded from the study according to the ex-
clusion criteria. Thus, the final patient sample consisted of
247 women, all of whom agreed to participate after being
informed of the aim and procedure of the study. Partici-
pants aged from 26 to 70 years, with a mean (SD) =
47.45(7.43) years. About 40.5 % of the patients were from
urban areas and 59.5 % were from rural areas. Most
(89.5 %) of the patients were married, 7.3 % were divorced,
and 3.2 % were widowed. They had received a mean (SD)
Li et al. BMC Women's Health  (2015) 15:91 Page 2 of 8
of 9.77(3.42) years of schooling. The employment status of
the patients reported were: employed (77.3 %), housewife
(15.4 %), and retired (7.3 %).
Healthy comparison group
We recruited the healthy women from Changsha and the
surrounding area for comparison. Eligible women had self-
reported good physical health and spoke Chinese. Women
with the following conditions were excluded: (1) history of
any type of cancer, (2) known untreated or unstable major
medical conditions, (3) known major psychiatric or neuro-
logical disorders that would interfere with completion of
the measures, and (4) history of substance abuse.
Three hundred and eighty-one women volunteered to
participate. Nineteen of them were excluded from the
study, leaving 362 women as health controls. The ages of
participants ranged from 25 to 68 years, with a mean
(SD) = 46.59 (7.57) years. Among the 362 women, 39.2 %
were from urban areas and 60.8 % were from rural areas.
The majority (93.1 %) of the healthy women were married,
4.4 % were divorced, and 2.5 % were widowed. They had
received a mean (SD) of 9.53 (3.43) years of schooling.
The employment status reported were: employed (74.3 %),
housewife (10.8 %), and retired (14.9 %).
Procedure
The research procedure of the current study was approved
by the Ethics Committee of the Second Xiangya Hospital,
Central South University. After participants provided writ-
ten informed consent, trained psychology students admin-
istered structured questionnaires in face-to-face
interviews to collect information on demographic, emo-
tional control, anxiety and depressive symptoms.
Measures
Demographics form
Demographic data including: age, years of schooling,
long-term residence, marital status and employment
status.
Center for Epidemiological Studies Depression Scale (CES-D)
The CES-D is a 20-item self-report questionnaire that
assesses depressive symptoms in general population. For
each item, individuals are asked to describe how often
they have experienced a given symptom over the last
week, and respond on a 4-point scale ranging from 0
(not at all) to 3 (a lot). Higher scores indicate higher
levels of such symptoms. The CES-D possesses strong
reliability and validity in clinical and nonclinical adults
[25, 26]. The cronbach’s α coefficient of CES-D in
current study was 0.88.
The beck anxiety inventory (BAI)
The BAI is a 21-item self-report inventory that measures
the severity of anxiety symptoms in the last week. Items
are rated on a 4-point scale ranging from 0 (not at all)
to 3 (severely, I could barely stand it), with higher scores
indicating higher levels of anxiety symptoms [27]. Good
psychometric properties have been demonstrated in a
variety of clinical populations, including breast cancer
patients [28]. The cronbach’s α coefficient of BAI in
current study was 0.87.
The Chinese version of courtauld emotional control scale
(CECS)
The original CECS was developed to assess the extent of
emotional control when a particular negative emotion is
experienced. It contains 21 items separated into three sub-
scales for the report of the suppression or the expression
of feelings towards anger, anxiety, and unhappiness (de-
pressed mood). Individuals are asked to response to the
phrases such as “When I feel angry, I bottle it up” on a 4-
point scale ranging from 1 (almost never) to 4 (almost al-
ways). The total emotional suppression scores are
summed by three subscale scores, with higher scores indi-
cating higher levels of emotional suppression. In previous
research, the CECS has shown good reliability [29].
The Chinese version of CECS was developed through
the procedures of translation and back translation, as well
as reference to the version developed by Ho et al. [24] to
ensure the meaning of each statement corresponded ac-
curately to the meaning of the original one. In our previ-
ous research, the Chinese version of CECS was proved to
be applicable for Chinese women with breast cancer [30].
In the current sample, CECS and its subscales exhibited
strong internal consistency: 0.96 (CECS), 0.89 (anger),
0.91 (anxiety), and 0.92 (depressed mood).
Analyses
Descriptive analyses, analysis of variance, and hierarch-
ical regression analyses were performed by SPSS 17.0
software with a 5 % level of significance. The incidence
rates of depressive symptoms were calculated according
to the cutoff CES-D score of 16 established by Radolff:
the CES-D score of 16 to 26 indicating clinical depres-
sive symptoms, and CES-D score ≥27 indicating severe
depressive symptoms [31]. Analyses of variance were
conducted to investigate differences on depressive symp-
toms and emotional suppression tendencies between
two groups. Bivariate correlations between age, years of
schooling, emotional suppression, anxiety symptoms and
depressive symptoms for all participants were analyzed
using Pearson correlations or Spearman correlations de-
pending on the distribution of variables. Hierarchical re-
gression analyses were performed to examine the effect
of the three emotional suppression tendencies on
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depressive symptoms in participants. As anxiety may be
closely related to depressive symptoms, we controlled
levels of anxiety in our regression analyses. Collinearity
between independent variables was tested based on vari-
ance inflation factors and tolerances [32].
Results
Demographic data
Table 1 showed demographic characteristics of each
group. There was no statistically significant difference
between patients and healthy women in demographic
variables except for the employment status.
Descriptive statistics
Table 2 showed the descriptive statistics for depression
symptoms, anxiety symptoms and emotional suppres-
sion. The mean (SD) score of CES-D in patients was
21.58 (9.82). More than one third (36.4 %) of the
patients had scores of 16 or higher, and 36.0 % reported
scores of 27 or higher. The mean (SD) score of CES-D
in healthy women was 14.90 (6.65). About 34.8 % of the
healthy women had scores of 16 or higher, and only
5.2 % of them had scores of 27 or higher. The total CES-
D scores were significantly different between two groups
(p < 0.001; Cohen’s d = 0.80). The prevalence of three
levels of depressive symptoms were significantly different
between two groups (χ2 = 111.530; p < 0.001); patients
had lower incidence rate of no depressive symptoms and
higher rate of severe depressive symptoms.
The total BAI scores were significantly different be-
tween two groups (p < 0.001; Cohen’s d = 0.92). Signifi-
cant differences on three emotional suppression
tendencies and total emotional suppression were found
between patients and healthy women (p < 0.001; Cohen’s d
ranged from 0.51 to 0.77).
Bivariate correlations between variables
We examined the relationships between age, years of
schooling, emotional suppression, anxiety symptoms and
depressive symptoms, and Pearson correlation coeffi-
cients and Spearman correlation coefficient were pre-
sented in Table 3. Age was not significantly correlated
with other variables (p > 0.05). Years of schooling was
significantly negatively correlated with emotional sup-
pression tendencies, and Spearman correlation coeffi-
cients ranged from −0.10 to −0.18 (p < 0.05). Pearson
correlation coefficients between the three subscales of
CECS ranged from 0.55 to 0.64 (p < 0.01).
Emotional suppression tendencies were found to be
significantly positively correlated with depressive symp-
toms and anxiety symptoms. Pearson correlation coeffi-
cients between CECS subscales and depressive symptoms
ranged from 0.50 to 0.66 (p < 0.01) while Pearson correl-
ation coefficients between CECS subscales and anxiety
symptoms ranged from 0.39 to 0.54 (p < 0.01). Anxiety
Table 1 Demographic data of the two groups
Patient group Healthy comparison group F or
χ2
p
(n = 247) (n = 362)
Age (years) 47.45 ± 7.43 46.59 ± 7.57 1.911 0.167
Years of schooling 9.77 ± 3.42 9.53 ± 3.43 0.713 0.399
Educational level (%) 1.021 0.796
Primary school 19.8 20.2
Junior high school 47.0 43.6
Senior middle school 17.0 19.9
College and above 16.2 16.3
Residence (%) 0.097 0.755
Urban 40.5 39.2
Rural 59.5 60.8
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symptoms were significantly positively correlated with de-
pressive symptoms (p < 0.01).
Hierarchical regression analyses
In order to further explore the effect of the three emo-
tional suppression tendencies on depressive symptoms
in women with breast cancer, multiple regression ana-
lyses were performed based on the correlation; the re-
sults were shown in Table 4. The regression equation for
model 1 was significant when group membership (1 =
patients, 2 = controls) was the sole predictor of depres-
sive symptoms (F = 100.303, p < 0.001). The regression
equation for model 2 was also significant when anxiety
symptoms were entered (F = 404.997, p < 0.001). The
final model was significant when emotional suppression
tendencies were entered (F = 230.751, p < 0.001), with a
R2 change of 0.085, indicating that emotional suppres-
sion accounted for 8.5 % of the variance of depressive
symptoms after controlling the effects of group member-
ship and levels of anxiety symptoms. However, the re-
gression coefficient was not significant for depression
suppression and anxiety suppression, whereas anger sup-
pression had significant effect on depressive symptoms
among breast cancer patients (p < 0.05).
Discussion
Previous studies have found that most breast cancer pa-
tients report psychological distress and may be in need
of emotional help [33], especially during the first
24 months after diagnosis [34]. In current study, the
incidence rates of clinical depressive symptoms and se-
vere depressive symptoms in women newly diagnosed
with breast cancer were 36.4 and 36.0 % respectively.
These rates are higher than findings from previous stud-
ies using the same instrument for assessing the depres-
sive symptoms in patients under later-stages treatment
for breast cancer [15, 35]. Our findings suggest that pa-
tients who are newly diagnosed with breast cancer are at
higher risk of developing depressive symptoms. Never-
theless, methodologically more rigorous assessments
(e.g., clinical interview) should be conducted to deter-
mine if these patients meet the criteria for clinically sig-
nificant depression.
Some researchers have argued that emotional sup-
pression may be an important risk factor for cancer.
Individuals who adopt a style of emotion suppression
in response to negative emotions throughout adult life
are more likely to be diagnosed with breast cancer
[36]. Similar findings have been found in other dis-
eases [37]. The current study showed that women
with breast cancer in Mainland China used higher
level of emotional suppression than healthy women.
Our findings suggest that a relative high level of emo-
tional suppression is not conducive to women’s
health, even though forbearance, the mastering of
maintaining harmonious relations with others, is gen-
erally considered a valuable character trait in women
according to traditional Chinese culture [23]. Support-
ive–expressive therapy for those diagnosed with can-
cer in previous study may also be helpful for breast
Table 2 CES-D, BAI and CECS means and standard deviations
Patient group Healthy comparison group F Cohen’s d
(n = 247) (n = 362)
Depression symptoms 21.58 ± 9.82 14.90 ± 6.65 100.303*** 0.80
Anxiety symptoms 13.58 ± 7.15 6.93 ± 7.36 122.854*** 0.92
Anger Suppression 19.03 ± 5.87 15.26 ± 3.73 93.855*** 0.77
Anxiety Suppression 18.56 ± 5.94 16.05 ± 3.67 41.674*** 0.51
Depression Suppression 18.63 ± 6.06 15.79 ± 4.06 48.149*** 0.55
Total emotional suppression 56.23 ± 17.12 47.09 ± 9.93 69.066*** 0.65
***p < 0.001
Table 3 Bivariate correlation coefficients between variables
Depressive symptoms 1 2 3 4 5 6
1. Age 0.01 —
2. Years of schooling −0.05 −0.02 —
3. Anxiety Symptoms 0.75** 0.05 −0.06 —
4. Anger Suppression 0.66** −0.01 −0.10* 0.54** —
5. Anxiety Suppression 0.50** −0.02 −0.18** 0.39** 0.55** —
6. Depression Suppression 0.58** −0.02 −0.16** 0.45** 0.64** 0.60** —
7. Total emotional suppression 0.62** −0.03 −0.16** 0.50** 0.83** 0.81** 0.85**
*p < 0.05, **p < 0.01
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cancer prevention in mainland China, and future re-
search should focus on this field.
Consistent with previous research [21], examination of
the correlations between the emotional suppression and
depressive symptoms revealed that participants with
controlled emotional coping style have higher level of
depressive symptoms. Findings from regression analyses
implicated emotional suppression had a significant effect
on the depressive symptoms; higher scores on anger
suppression predicted higher level of depressive symp-
toms after controlling for the effects of group member-
ship and levels of anxiety symptoms. Depression
suppression and anxiety suppression had no significant
effect on depressive symptoms, though both subscale
scores were significantly correlated with CES-D scores.
These results, which were similar to findings of Iwamit-
su’s study [38], implied that suppression of different
negative emotion had different psychological outcomes.
Therefore, it is important to encourage suppressive pa-
tients to express negative emotion correctly and
appropriately.
Anger suppression has been found to be linked with
increased risk of adverse cardiac events, greater pain,
and poor immune function [39]. In current study, when
considering the three emotional suppression tendencies
concurrently, anger suppression showed a unique role in
predicting depressive symptoms in Chinese women with
breast cancer. However, Ando et al. [40] found that only
anxiety suppression could significantly predict the level
of psychological stress of breast cancer patients before
the diagnosis. The possible reason for this inconsistency
may be that anger expression is more socially undesir-
able for Chinese women and they seem to have more
difficulty in expressing anger than anxiety and depres-
sion. As mentioned by Ho et al., Hong Kong Chinese
cancer survivors had higher levels of anger suppression
compared to British counterparts [24]. What is more,
patients are considered to be angry when realizing the
authenticity and immutability of a diagnosis of life-
threatening disease. As a result, psychosocial interven-
tion in breast cancer patients targeting anger expression
may be effective for alleviating symptoms of depression.
Further studies are required to confirm the effect of
anger expression on psychological distress.
Strength and limitation
A key strength of the present study was that we re-
cruited a matched control group for comparison, a
methodological improvement from previous studies.
High rates of participation (98.9 and 95.0 % of patients
and controls, respectively) and complete response on all
of the questionnaires significantly helped to reduce er-
rors caused by missing data. Finally, our study was the
first to illustrate the importance of assessing emotional
suppression tendencies in Chinese women newly diag-
nosed with breast cancer.
There were several limitations worth noting of the
current study. Firstly, because of the self-report nature
of the CES-D, it was difficult to draw conclusions about
clinically diagnosed depression, which should be in-
cluded in the future study. Secondly, measures of de-
pressive symptoms were only taken at one time point.
Future studies with multiple time points would help to
explore the relationships between emotional suppression
tendencies and changes in depressive symptoms over
time in breast cancer patients.
Conclusions
The findings of this study suggested that the majority of
Chinese women newly diagnosed with early breast can-
cer had clinical or severe depressive symptoms, and that
these patients presented a controlled emotion coping
style. Our study lends further empirical evidence that
emotional suppression is associated with the level of de-
pressive symptoms in women newly diagnosed with
breast cancer. Finally, anger suppression may play a
unique role in predicting symptoms of depression in
women with breast cancer.
Table 4 Regression analysis for emotional suppression in predicting depressive symptoms
B SEB t F R2 Adjusted
R2
Step 1 100.303*** 0.142 0.140
Group −6.682 −0.377 −10.015***
Step 2 404.997*** 0.572 0.571
Anxiety symptoms 0.787 0.719 24.682***
Step 3 230.751*** 0.657 0.654
Anger suppression 0.464 0.269 5.473***
Depression suppression 0.159 0.094 1.977
Anxiety suppression −0.006 −0.003 −0.083
***p < 0.001
Li et al. BMC Women's Health  (2015) 15:91 Page 6 of 8
Competing interests
The authors declare that they have no competing interests. The authors alone
are responsible for the content and writing of the paper.
Authors’ contributions
LL, YY and XZ conceived and designed the study. LL, JH and YW organized and
supervised data collection and inputting. LL drafted the paper; organized and
supervised the data analysis. JY provided critical comments on various drafts of
the paper. JZ helped to organize data collection, commented on drafts of the
paper. All authors read and approved the final manuscript.
Acknowledgments
The research reported in this article was supported by National Key Technologies
R&D program in the 11th 5-year plan from the Ministry of Science and Technology
of the People’s Republic of China, Grant No. 2009BAI77B06.
Author details
1Medical Psychological Institute, Second Xiangya Hospital, Central South
University, Changsha, Hunan 410011, P. R. China. 2Department of Medical
Psychology, Public Health Institute of Harbin Medical University, Harbin,
China. 3The First Affiliated Hospital, Wenzhou Medical College, Wenzhou,
China. 4National Technology Institute of Psychiatry, Central South University,
Changsha, China.
Received: 1 May 2014 Accepted: 13 October 2015
References
1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of
worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer.
2010;127(12):2893–917.
2. Youlden DR, Cramb SM, Dunn NA, Muller JM, Pyke CM, Baade PD. The
descriptive epidemiology of female breast cancer: an international comparison
of screening, incidence, survival and mortality. Cancer Epidemiol.
2012;36(3):237–48.
3. Porter P. “Westernizing” women’s risks? Breast cancer in lower-income
countries. N Engl J Med. 2008;358(3):213–6.
4. Chochinov HM. Depression in cancer patients. Lancet Oncol. 2001;2(8):499–505.
5. Rayner L, Price A, Hotopf M, Higginson IJ. The development of evidence-
based European guidelines on the management of depression in palliative
cancer care. Eur J Cancer. 2011;47(5):702–12.
6. Fann JR, Thomas-Rich AM, Katon WJ, Cowley D, Pepping M, McGregor BA,
et al. Major depression after breast cancer: a review of epidemiology and
treatment. Gen Hosp Psychiatry. 2008;30(2):112–26.
7. Hopwood P, Sumo G, Mills J, Haviland J, Bliss JM. The course of anxiety and
depression over 5 years of follow-up and risk factors in women with early
breast cancer: results from the UK Standardisation of Radiotherapy Trials
(START). Breast. 2010;19(2):84–91.
8. Schmid-Büchi S, Halfens RJ, Dassen T, Borne B. Psychosocial problems and
needs of posttreatment patients with breast cancer and their relatives. Eur J
Oncol Nurs. 2011;15(3):260–6.
9. Badr H, Milbury K. Associations between depression, pain behaviors, and
partner responses to pain in metastatic breast cancer. Pain.
2011;152(11):2596–604.
10. Montgomery GH, Bovbjerg DH. Presurgery distress and specific response
expectancies predict postsurgery outcomes in surgery patients confronting
breast cancer. Health Psychol. 2004;23(4):381.
11. Paraska KK, Bender CM. Cognitive dysfunction following adjuvant
chemotherapy for breast cancer: two case studies. Oncology nursing forum,
Oncology Nursing Society. 2003;30(3):473–8.
12. Reich M, Lesur A, Perdrizet-Chevallier C. Depression, quality of life and
breast cancer: a review of the literature. Breast Cancer Res Treat.
2008;110(1):9–17.
13. Satin JR, Linden W, Phillips MJ. Depression as a predictor of disease
progression and mortality in cancer patients. Cancer. 2009;115(22):5349–61.
14. Burgess C, Cornelius V, Love S, Graham J, Richards M, Ramirez A. Depression
and anxiety in women with early breast cancer: five year observational
cohort study. BMJ. 2005;330(7493):702.
15. Ganz PA, Kwan L, Stanton AL, Krupnick JL, Rowland JH, Meyerowitz BE, et al.
Quality of life at the end of primary treatment of breast cancer: first results
from the moving beyond cancer randomized trial. J Natl Cancer Inst.
2004;96(5):376–87.
16. Roscoe JA, Morrow GR, Hickok JT, Mustian KM, Griggs J, Matteson SE, et al.
Effect of paroxetine hydrochloride (Paxil®) on fatigue and depression in
breast cancer patients receiving chemotherapy. Breast Cancer Res Treat.
2005;89(3):243–9.
17. Khan F, Amatya B, Pallant JF, Rajapaksa I. Factors associated with long-term
functional outcomes and psychological sequelae in women after breast
cancer. Breast. 2012;21(3):314–20.
18. Temoshok L. Personality, coping style, emotion and cancer: towards an
integrative model. Cancer Surv. 1986;6(3):545–67.
19. Iwamitsu Y, Shimoda K, Abe H, Okawa M. Anxiety, emotional suppression,
and psychological distress before and after breast cancer diagnosis.
Psychosomatics. 2005;46(1):19–24.
20. Schlatter MC, Cameron LD. Emotional suppression tendencies as predictors
of symptoms, mood, and coping appraisals during AC chemotherapy for
breast cancer treatment. Ann Behav Med. 2010;40(1):15–29.
21. Classen C, Koopman C, Angell K, Spiegel D. Coping styles associated with
psychological adjustment to advanced breast cancer. Health Psychol.
1996;15(6):434.
22. Spiegel D, Giese-Davis J. Reduced emotional control as a mediator of
decreasing distress among breast cancer patients in group therapy. Int
Congr Ser. 2002;1241:37–40.
23. Butler EA, Lee TL, Gross JJ. Emotion regulation and culture: are the social
consequences of emotion suppression culture-specific? Emotion.
2007;7(1):30.
24. Ho RT, Chan CL, Ho SM. Emotional control in Chinese female cancer survivors.
Psychooncology. 2004;13(11):808–17.
25. Yang HJ, Soong WT, Kuo PH, Chang H, Chen WJ. Using the CES-D in a two-
phase survey for depressive disorders among nonreferred adolescents in
Taipei: a stratum-specific likelihood ratio analysis. J Affect Disord.
2004;82(3):419–30.
26. Hann D, Winter K, Jacobsen P. Measurement of depressive symptoms in
cancer patients: evaluation of the Center for Epidemiological Studies
Depression Scale (CES-D). J Psychosom Res. 1999;46(5):437–43.
27. Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring
clinical anxiety: psychometric properties. J Consult Clin Psychol.
1988;56(6):893.
28. Liu Y, Pérez M, Schootman M, Aft RL, Gillanders WE, Jeffe DB. Correlates
of fear of cancer recurrence in women with ductal carcinoma in situ
and early invasive breast cancer. Breast Cancer Res Treat.
2011;130(1):165–73.
29. Watson M, Greer S. Development of a questionnaire measure of emotional
control. J Psychosom Res. 1983;27(4):299–305.
30. Li L, Xiong Z, Chen G, Wang Y, Ling C, Yang Y. The Chinese version of the
courtauld emotional control scale: reliability and validity. China Journal of
Clinical Psychology. 2013;21(2):2006–208 (In Chinese).
31. Radolff LS. The CES-D scale: A self-report depression scale for research in
the general population. Appl Psychol Meas. 1977;1(3):385–401.
32. Miles J, Shevlin M. Applying regression and correlation. London: Sage; 2003.
33. Giese-Davis J, DiMiceli S, Sephton S, Spiegel D. Emotional expression and
diurnal cortisol slope in women with metastatic breast cancer in
supportive-expressive group therapy: A preliminary study. Biol Psychol.
2006;73(2):190–8.
34. Stanton AL. Psychosocial concerns and interventions for cancer survivors. J
Clin Oncol. 2006;24(32):5132–7.
35. Broeckel JA, Jacobsen PB, Balducci L, Horton J, Lyman GH. Quality of life
after adjuvant chemotherapy for breast cancer. Breast Cancer Res Treat.
2000;62(2):141–50.
36. Greer S, Morris T. Psychological attributes of women who develop breast
cancer: a controlled study. J Psychosom Res. 1975;19:147–53.
37. Kossakowska MM, Cieścińska C, Jaszewska J, Placek WJ. Control of
negative emotions and its implication for illness perception among
psoriasis and vitiligo patients. J Eur Acad Dermatol Venereol.
2010;24(4):429–33.
38. Iwamitsu Y, Shimoda K, Abe H, Tani T, Okawa M, Buck R. The relation
between negative emotional suppression and emotional distress in
breast cancer diagnosis and treatment. Health Commun.
2005;18(3):201–15.
39. Penedo FJ, Dahn JR, Kinsinger D, Antoni MH, Molton I, Gonzalez JS, et al.
Anger suppression mediates the relationship between optimism and
Li et al. BMC Women's Health  (2015) 15:91 Page 7 of 8
natural killer cell cytotoxicity in men treated for localized prostate cancer. J
Psychosom Res. 2006;60(4):423–7.
40. Ando N, Iwamitsu Y, Kuranami M, Okazaki S, Wada M, Yamamoto K, et al.
Psychological characteristics and subjective symptoms as determinants of
psychological distress in patients prior to breast cancer diagnosis. Support
Care Cancer. 2009;17(11):1361–70.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Li et al. BMC Women's Health  (2015) 15:91 Page 8 of 8
